| First Author | Maginot M | Year | 2015 |
| Journal | Bone | Volume | 81 |
| Pages | 602-13 | PubMed ID | 26303287 |
| Mgi Jnum | J:228436 | Mgi Id | MGI:5707094 |
| Doi | 10.1016/j.bone.2015.08.018 | Citation | Maginot M, et al. (2015) The in vivo role of DMP-1 and serum phosphate on bone mineral composition. Bone 81:602-13 |
| abstractText | Human DMP1 mutations or Dmp1-null (KO) mice display hypophosphatemia rickets, suggesting a causative role of low phosphate (P) in development of osteomalacia. To address the direct contribution of P to the in vivo bone mineralization we analyzed the properties of femurs obtained from Dmp1 null mice and wild type (WT) mice under a normal or high phosphorous (HiP) diet using combined assays, including histological examination, micro computed tomography (muCT), X-ray absorption near edge structure (XANES) spectroscopy and Raman spectroscopy. Histology and XANES indicate that WT mice have phosphate coordinated with Ca in the form of hydroxyapatite and tricalcium phosphate, while the KO mice have poorly coordinated soluble phosphates in their structure in both the normal and HiP diets. Raman spectroscopy and XANES indicate a higher carbonate/phosphate ratio and a low mineral/matrix ratio in the osteoid clusters in the KO femurs, which was only partially improved by HiP diets. Thus, we conclude that the hypophosphatemia induced osteomalacia phenotype in Dmp1 KO mice is contributed by at least two factors: the low Pi level and the DMP1 local function in mineralization. |
